Kurzporträt
Manager
Manager | Titel | Alter | Seit |
---|---|---|---|
C. Trenary
CEO | Chief Executive Officer | 66 | 07.07.21 |
Lawrence Kenyon
DFI | Director of Finance/CFO | 58 | 15.09.15 |
Surendra Sharma
CTO | Chief Tech/Sci/R&D Officer | - | 19.01.23 |
Terry Dagnon
COO | Chief Operating Officer | 62 | 01.11.18 |
Alicia Tozier
SAM | Sales & Marketing | - | 02.03.22 |
Joel Prieve
PRN | Corporate Officer/Principal | - | 08.02.22 |
Jeff Evanson
PRN | Corporate Officer/Principal | 55 | 01.11.18 |
Jennifer Kissner
PRN | Corporate Officer/Principal | - | 26.04.19 |
Aufsichtsräte
Aufsichtsräte | Titel | Alter | Seit |
---|---|---|---|
Randy Thurman
CHM | Chairman | 74 | 13.04.18 |
Kurt Hilzinger
BRD | Director/Board Member | 63 | 11.12.15 |
C. Trenary
CEO | Chief Executive Officer | 66 | 07.07.21 |
Lawrence Kenyon
DFI | Director of Finance/CFO | 58 | 15.09.15 |
Yazan Haddadin
BRD | Director/Board Member | 48 | 31.10.17 |
Julian Gangolli
BRD | Director/Board Member | 66 | 20.04.20 |
Gerd Auffarth
BRD | Director/Board Member | 59 | 20.04.20 |
Julia Haller
BRD | Director/Board Member | 69 | 11.08.22 |
Director/Board Member | 39 | 11.09.17 | |
Andong Huang
BRD | Director/Board Member | 27 | 19.06.20 |
Anteilsklasse
Vote | Menge | Streubesitz | Konzerneigene Aktien | Total Float | |
---|---|---|---|---|---|
Aktie A | 1 | 23 298 495 | 13 636 212 ( 58,53 %) | 0 | 58,53 % |
Unternehmenskontakt
Outlook Therapeutics, Inc.
111 South Wood Avenue Unit 100
08830, Iselin
+609 619 3990
http://www.outlooktherapeutics.comSektor
% 1. Jan. | Kap. | |
---|---|---|
+33,63 % | 50,85 Mrd. | |
-0,09 % | 42,82 Mrd. | |
+49,62 % | 42,03 Mrd. | |
-4,96 % | 29,55 Mrd. | |
+11,18 % | 26,11 Mrd. | |
-21,95 % | 19,13 Mrd. | |
+8,61 % | 13,05 Mrd. | |
+28,31 % | 12,16 Mrd. | |
+24,73 % | 12,08 Mrd. |